908 Devices Inc (MASS)
5.69
-0.08
(-1.39%)
USD |
NASDAQ |
May 10, 16:00
5.69
0.00 (0.00%)
After-Hours: 20:00
908 Devices Cash from Operations (TTM): -23.77M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -23.77M |
December 31, 2023 | -25.06M |
September 30, 2023 | -28.24M |
June 30, 2023 | -28.58M |
March 31, 2023 | -31.11M |
December 31, 2022 | -20.93M |
September 30, 2022 | -25.03M |
Date | Value |
---|---|
June 30, 2022 | -23.02M |
March 31, 2022 | -19.92M |
December 31, 2021 | -29.08M |
September 30, 2021 | -17.53M |
June 30, 2021 | -6.409M |
March 31, 2021 | -2.334M |
December 31, 2020 | 4.131M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-31.11M
Minimum
Mar 2023
4.131M
Maximum
Dec 2020
-19.78M
Average
-23.39M
Median
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -36.91M |
Retractable Technologies Inc | 2.767M |
Xtant Medical Holdings Inc | -9.515M |
Asensus Surgical Inc | -63.63M |
Catheter Precision Inc | -20.62M |